NASDAQ:ALVR - Nasdaq - US0198181036 - Common Stock - Currency: USD
Combined company expected to trade on Nasdaq under “KLRS” after closing...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips AlloVir (NASDAQ:ALVR) just reported results for the second quarter of 2024.Allo...
ALVR stock results show that AlloVir beat analyst estimates for earnings per share the second quarter of 2024.
ALVR stock results show that AlloVir missed analyst estimates for earnings per share the first quarter of 2024.
Mentions: EMKR
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Mentions: EMKR
Kalaris is a clinical-stage biopharmaceutical company founded by Samsara BioCapital and focused on development of TH103, a novel, differentiated and...
/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against AlloVir, Inc. ("AlloVir" or the "Company") (NASDAQ: ALVR). The class...